Actively Recruiting
Ambulatory Surgical Center Implantable Cardioverter-Defibrillator Outcomes Registry
Led by QuesGen Systems Inc · Updated on 2021-01-22
500
Participants Needed
1
Research Sites
574 weeks
Total Duration
On this page
Sponsors
Q
QuesGen Systems Inc
Lead Sponsor
C
Cardio Surgical Partners
Collaborating Sponsor
AI-Summary
What this Trial Is About
The primary objectives for the registry is to evaluate the overall incidence of serious complications or adverse events for primary implants and replacement devices, and assess the cost and time efficiency for both physicians and patients. The Registry is a multi ASC data collection registry. Data collection will occur at the time of screening, implant, and 2 weeks after implant at the time of wound check.
CONDITIONS
Official Title
Ambulatory Surgical Center Implantable Cardioverter-Defibrillator Outcomes Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Physician recommendation to receive the implant in an Ambulatory Surgical Center (ASC)
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cardio Surgical Partners, LLC
Lehi, Utah, United States, 84043
Actively Recruiting
Research Team
M
Michael Jarrett, MBA
CONTACT
M
Martin Jorgensen, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here